Inhibitors of influenza viruses replication
US9518056B2 · kind B2 · utility
Assignee
Inventors
- Paul S. Charifson
- Michael P. Clark
- Upul K. Bandarage
- Randy S. Bethiel
- John J. Court
- Hongbo Deng
- Ioana Davies
- John P. Duffy
- Luc Farmer
- Huai Gao
- Wenxin Gu
- Dylan H. Jacobs
- Joseph M. Kennedy
- Mark Ledeboer
- Brian Ledford
- Francois Maltais
- Emanuele Perola
- Tiansheng Wang
- M. Woods Wannamaker
- Randal Byrn
- Yi Zhou
- Chao Lin
- Min Jiang
- Steven Jones
- Ursula A. Germann
- Francesco G. Salituro
- Ann Dak-Yee Kwong
Key dates
| Filing date | Nov 2, 2015 |
| Grant date | Dec 13, 2016 |
| Priority date | — |
| Expiry date | Nov 2, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I):or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.